$66.70
-2.86 (-4.11%)
At Close: Jun 03, 2026
A Bullish Play on Small-Caps Could Already Be Brewing
01:30pm, Friday, 12'th Aug 2022
The Direxion Daily Small Cap Bull 3X Shares (TNA) is up over 40% the past month, highlighting what could be a small-cap rally brewing after a rough first half of 2022, particularly for small-caps.
With Recession Fears Looming, Small-Cap Bears Could Stay Ahead of Bulls
01:33pm, Wednesday, 06'th Jul 2022
Small-caps have been feeling the brunt of the downward pressure on stocks, even more so than their large-cap peers, as usual. With recession fears constantly looming, this could keep the bears ahead o
Are Small-Caps Ready to Come Back in a Big Way?
01:58pm, Thursday, 23'rd Jun 2022
Small-cap equities can give traders amplified gains, but the same can be said when the markets move in the opposite direction the way they have been for the first half of 2022. However, when things ev
Large Caps Are Proving Their Mettle in Volatile Market
03:02pm, Tuesday, 07'th Jun 2022
In times of heavy market volatility, large caps are proving their mettle when it comes to leveraging exchange-traded fund (ETF) products from Direxion Investments. These larger cap companies typically
7 Undervalued Stocks to Buy Before Investors Catch On
08:02am, Wednesday, 18'th May 2022
Wall Street has punished these companies and funds excessively this year, so we are sharing these undervalued stocks to catch near 2020 lows. The post 7 Undervalued Stocks to Buy Before Investors Catc
A Guide to the 10 Most-Popular Leveraged ETFs
12:47pm, Monday, 09'th May 2022
Amid huge volatility and uncertainty, the appeal for leveraged ETFs has been soaring although these products occupy a small slice of the ETF space.
CURE: One Of The Best Performing 3X Shares ETF
08:13am, Thursday, 24'th Mar 2022
CURE: One Of The Best Performing 3X Shares ETF
SSO: Leveraged ETF Decay Costs February 2022 Update
02:38pm, Wednesday, 02'nd Mar 2022
SSO: Leveraged ETF Decay Costs February 2022 Update
2 ETFs to Play More Downside or Future Upside for Small-Caps
01:16pm, Thursday, 24'th Feb 2022
When it comes to market movements, small-caps could be a prime example of when market cap size inversely correlates with volatility. That said, however, traders have a couple of options to play the am
3 Leveraged ETF Stocks to Buy During This Extreme Uncertainty
11:51am, Tuesday, 22'nd Feb 2022
Here are 3 stocks to buy on dips from scary geopolitical risks from Russia. These leveraged ETFs move extremely fast so bring your Dramamine.
Time To Derisk And Optimize Your Riskier Leveraged ETF Positions
12:49pm, Friday, 04'th Feb 2022
Time To Derisk And Optimize Your Riskier Leveraged ETF Positions
TNA ETF: Time To Bet On The Losers Again
09:26am, Thursday, 16'th Dec 2021
Small cap stocks have been a disappointment during this year of recovery from the COVID-19 crisis. But two factors make me think that now could be the time to bet on the underdog again: (1) market myo
Karp Capital Management Corp Raises Stock Position in Direxion Daily Small Cap Bull 3X Shares (NYSEARCA:TNA)
01:22pm, Saturday, 11'th Dec 2021 Dakota Financial News
Karp Capital Management Corp lifted its stake in shares of Direxion Daily Small Cap Bull 3X Shares (NYSEARCA:TNA) by 9.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 34,272 shares of the exchange traded funds stock after buying an additional 3,098 shares during []
Direxion Daily Small Cap Bull 3X Shares (NYSEARCA:TNA) Shares Acquired by United Maritime Capital LLC
04:48pm, Thursday, 09'th Dec 2021 Dakota Financial News
United Maritime Capital LLC raised its position in shares of Direxion Daily Small Cap Bull 3X Shares (NYSEARCA:TNA) by 18.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 52,700 shares of the exchange traded funds stock after acquiring an additional 8,200 []
Best Leveraged ETF Areas of Last Week
09:14am, Monday, 08'th Nov 2021
Wall Street was at the record high last week due to upbeat corporate earnings, strong jobs data and Pfizer's pill study.
Sign In
Buy TNA